IBDEI0J6 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,8627,2)
;;=^5001846
;;^UTILITY(U,$J,358.3,8628,0)
;;=D61.82^^39^401^180
;;^UTILITY(U,$J,358.3,8628,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8628,1,3,0)
;;=3^Myelophthisis
;;^UTILITY(U,$J,358.3,8628,1,4,0)
;;=4^D61.82
;;^UTILITY(U,$J,358.3,8628,2)
;;=^334037
;;^UTILITY(U,$J,358.3,8629,0)
;;=D47.9^^39^401^181
;;^UTILITY(U,$J,358.3,8629,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8629,1,3,0)
;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
;;^UTILITY(U,$J,358.3,8629,1,4,0)
;;=4^D47.9
;;^UTILITY(U,$J,358.3,8629,2)
;;=^5002260
;;^UTILITY(U,$J,358.3,8630,0)
;;=D53.9^^39^401^185
;;^UTILITY(U,$J,358.3,8630,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8630,1,3,0)
;;=3^Nutritional Anemia,Unspec
;;^UTILITY(U,$J,358.3,8630,1,4,0)
;;=4^D53.9
;;^UTILITY(U,$J,358.3,8630,2)
;;=^5002298
;;^UTILITY(U,$J,358.3,8631,0)
;;=D47.4^^39^401^186
;;^UTILITY(U,$J,358.3,8631,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8631,1,3,0)
;;=3^Osteomyelofibrosis
;;^UTILITY(U,$J,358.3,8631,1,4,0)
;;=4^D47.4
;;^UTILITY(U,$J,358.3,8631,2)
;;=^5002259
;;^UTILITY(U,$J,358.3,8632,0)
;;=D51.3^^39^401^210
;;^UTILITY(U,$J,358.3,8632,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8632,1,3,0)
;;=3^Vitamin B12 Deficiency Anemia,Other
;;^UTILITY(U,$J,358.3,8632,1,4,0)
;;=4^D51.3
;;^UTILITY(U,$J,358.3,8632,2)
;;=^5002287
;;^UTILITY(U,$J,358.3,8633,0)
;;=D77.^^39^401^62
;;^UTILITY(U,$J,358.3,8633,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8633,1,3,0)
;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
;;^UTILITY(U,$J,358.3,8633,1,4,0)
;;=4^D77.
;;^UTILITY(U,$J,358.3,8633,2)
;;=^5002396
;;^UTILITY(U,$J,358.3,8634,0)
;;=D58.2^^39^401^88
;;^UTILITY(U,$J,358.3,8634,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8634,1,3,0)
;;=3^Hemoglobinopathies,Other
;;^UTILITY(U,$J,358.3,8634,1,4,0)
;;=4^D58.2
;;^UTILITY(U,$J,358.3,8634,2)
;;=^87629
;;^UTILITY(U,$J,358.3,8635,0)
;;=C88.8^^39^401^110
;;^UTILITY(U,$J,358.3,8635,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8635,1,3,0)
;;=3^Malig Immunoproliferative Diseases,Other
;;^UTILITY(U,$J,358.3,8635,1,4,0)
;;=4^C88.8
;;^UTILITY(U,$J,358.3,8635,2)
;;=^5001750
;;^UTILITY(U,$J,358.3,8636,0)
;;=D70.8^^39^401^183
;;^UTILITY(U,$J,358.3,8636,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8636,1,3,0)
;;=3^Neutropenia,Other
;;^UTILITY(U,$J,358.3,8636,1,4,0)
;;=4^D70.8
;;^UTILITY(U,$J,358.3,8636,2)
;;=^334042
;;^UTILITY(U,$J,358.3,8637,0)
;;=D59.4^^39^401^184
;;^UTILITY(U,$J,358.3,8637,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8637,1,3,0)
;;=3^Nonautoimmune Hemolytic Anemias,Other
;;^UTILITY(U,$J,358.3,8637,1,4,0)
;;=4^D59.4
;;^UTILITY(U,$J,358.3,8637,2)
;;=^5002326
;;^UTILITY(U,$J,358.3,8638,0)
;;=D69.59^^39^401^190
;;^UTILITY(U,$J,358.3,8638,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8638,1,3,0)
;;=3^Secondary Thrombocytopenia,Other
;;^UTILITY(U,$J,358.3,8638,1,4,0)
;;=4^D69.59
;;^UTILITY(U,$J,358.3,8638,2)
;;=^5002369
;;^UTILITY(U,$J,358.3,8639,0)
;;=C22.7^^39^401^51
;;^UTILITY(U,$J,358.3,8639,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8639,1,3,0)
;;=3^Carcinomas of Liver,Other Spec
;;^UTILITY(U,$J,358.3,8639,1,4,0)
;;=4^C22.7
;;^UTILITY(U,$J,358.3,8639,2)
;;=^5000938
;;^UTILITY(U,$J,358.3,8640,0)
;;=D75.89^^39^401^61
;;^UTILITY(U,$J,358.3,8640,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0J6 3780 printed Apr 09, 2024@20:50:38 Page 2
IBDEI0J6 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,8627,2)
+2 ;;=^5001846
+3 ;;^UTILITY(U,$J,358.3,8628,0)
+4 ;;=D61.82^^39^401^180
+5 ;;^UTILITY(U,$J,358.3,8628,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,8628,1,3,0)
+8 ;;=3^Myelophthisis
+9 ;;^UTILITY(U,$J,358.3,8628,1,4,0)
+10 ;;=4^D61.82
+11 ;;^UTILITY(U,$J,358.3,8628,2)
+12 ;;=^334037
+13 ;;^UTILITY(U,$J,358.3,8629,0)
+14 ;;=D47.9^^39^401^181
+15 ;;^UTILITY(U,$J,358.3,8629,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,8629,1,3,0)
+18 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
+19 ;;^UTILITY(U,$J,358.3,8629,1,4,0)
+20 ;;=4^D47.9
+21 ;;^UTILITY(U,$J,358.3,8629,2)
+22 ;;=^5002260
+23 ;;^UTILITY(U,$J,358.3,8630,0)
+24 ;;=D53.9^^39^401^185
+25 ;;^UTILITY(U,$J,358.3,8630,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,8630,1,3,0)
+28 ;;=3^Nutritional Anemia,Unspec
+29 ;;^UTILITY(U,$J,358.3,8630,1,4,0)
+30 ;;=4^D53.9
+31 ;;^UTILITY(U,$J,358.3,8630,2)
+32 ;;=^5002298
+33 ;;^UTILITY(U,$J,358.3,8631,0)
+34 ;;=D47.4^^39^401^186
+35 ;;^UTILITY(U,$J,358.3,8631,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,8631,1,3,0)
+38 ;;=3^Osteomyelofibrosis
+39 ;;^UTILITY(U,$J,358.3,8631,1,4,0)
+40 ;;=4^D47.4
+41 ;;^UTILITY(U,$J,358.3,8631,2)
+42 ;;=^5002259
+43 ;;^UTILITY(U,$J,358.3,8632,0)
+44 ;;=D51.3^^39^401^210
+45 ;;^UTILITY(U,$J,358.3,8632,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,8632,1,3,0)
+48 ;;=3^Vitamin B12 Deficiency Anemia,Other
+49 ;;^UTILITY(U,$J,358.3,8632,1,4,0)
+50 ;;=4^D51.3
+51 ;;^UTILITY(U,$J,358.3,8632,2)
+52 ;;=^5002287
+53 ;;^UTILITY(U,$J,358.3,8633,0)
+54 ;;=D77.^^39^401^62
+55 ;;^UTILITY(U,$J,358.3,8633,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,8633,1,3,0)
+58 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
+59 ;;^UTILITY(U,$J,358.3,8633,1,4,0)
+60 ;;=4^D77.
+61 ;;^UTILITY(U,$J,358.3,8633,2)
+62 ;;=^5002396
+63 ;;^UTILITY(U,$J,358.3,8634,0)
+64 ;;=D58.2^^39^401^88
+65 ;;^UTILITY(U,$J,358.3,8634,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,8634,1,3,0)
+68 ;;=3^Hemoglobinopathies,Other
+69 ;;^UTILITY(U,$J,358.3,8634,1,4,0)
+70 ;;=4^D58.2
+71 ;;^UTILITY(U,$J,358.3,8634,2)
+72 ;;=^87629
+73 ;;^UTILITY(U,$J,358.3,8635,0)
+74 ;;=C88.8^^39^401^110
+75 ;;^UTILITY(U,$J,358.3,8635,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,8635,1,3,0)
+78 ;;=3^Malig Immunoproliferative Diseases,Other
+79 ;;^UTILITY(U,$J,358.3,8635,1,4,0)
+80 ;;=4^C88.8
+81 ;;^UTILITY(U,$J,358.3,8635,2)
+82 ;;=^5001750
+83 ;;^UTILITY(U,$J,358.3,8636,0)
+84 ;;=D70.8^^39^401^183
+85 ;;^UTILITY(U,$J,358.3,8636,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,8636,1,3,0)
+88 ;;=3^Neutropenia,Other
+89 ;;^UTILITY(U,$J,358.3,8636,1,4,0)
+90 ;;=4^D70.8
+91 ;;^UTILITY(U,$J,358.3,8636,2)
+92 ;;=^334042
+93 ;;^UTILITY(U,$J,358.3,8637,0)
+94 ;;=D59.4^^39^401^184
+95 ;;^UTILITY(U,$J,358.3,8637,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,8637,1,3,0)
+98 ;;=3^Nonautoimmune Hemolytic Anemias,Other
+99 ;;^UTILITY(U,$J,358.3,8637,1,4,0)
+100 ;;=4^D59.4
+101 ;;^UTILITY(U,$J,358.3,8637,2)
+102 ;;=^5002326
+103 ;;^UTILITY(U,$J,358.3,8638,0)
+104 ;;=D69.59^^39^401^190
+105 ;;^UTILITY(U,$J,358.3,8638,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,8638,1,3,0)
+108 ;;=3^Secondary Thrombocytopenia,Other
+109 ;;^UTILITY(U,$J,358.3,8638,1,4,0)
+110 ;;=4^D69.59
+111 ;;^UTILITY(U,$J,358.3,8638,2)
+112 ;;=^5002369
+113 ;;^UTILITY(U,$J,358.3,8639,0)
+114 ;;=C22.7^^39^401^51
+115 ;;^UTILITY(U,$J,358.3,8639,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,8639,1,3,0)
+118 ;;=3^Carcinomas of Liver,Other Spec
+119 ;;^UTILITY(U,$J,358.3,8639,1,4,0)
+120 ;;=4^C22.7
+121 ;;^UTILITY(U,$J,358.3,8639,2)
+122 ;;=^5000938
+123 ;;^UTILITY(U,$J,358.3,8640,0)
+124 ;;=D75.89^^39^401^61
+125 ;;^UTILITY(U,$J,358.3,8640,1,0)
+126 ;;=^358.31IA^4^2
